^
Association details:
| Biomarker: | MSH2 mutation |
|---|---|
| Cancer: | Pancreatic Ductal Adenocarcinoma |
| Regimen: | (leucovorin calcium + oxaliplatin + 5-fluorouracil + irinotecan) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Germline and somatic DNA damage repair gene mutations and overall survival in metastatic pancreatic ductal adenocarcinoma patients treated with FOLFIRINOX
Published date:
10/09/2018
Excerpt:
Mutations were seen in BRCA1 (N = 7), BRCA2 (N = 5), BRCA1/2 (N = 3), PALB2 (N = 3), MSH2 (N = 1) and FANCF (N = 1) of all the DDR genes sequenced...Cox regression (HR 0.37 [0.15-0.94], p = 0.04) showed presence of DDRGM was associated with improved OS....we found that the presence of germline and somatic DDRGM as well as germline BRCA1/2 mutations are associated with improved OS in PDAC patients treated with FOLFIRINOX.
DOI:
10.1093/annonc/mdy282.100
